Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.

Abstract

This study underscores the importance of starting IT as early as possible, at the lowest inhibitor titer and with high FVIII doses in order to maximize the chance of treatment success and minimize treatment costs.